CD276 Blockade Slows Gastric Cancer and Boosts Anti-PD-1 Immunotherapy in Preclinical Study
Blocking the CD276 molecule slowed gastric cancer growth and, combined with anti-PD-1 therapy, produced the strongest tumor suppression and increased ...
Blocking the CD276 molecule slowed gastric cancer growth and, combined with anti-PD-1 therapy, produced the strongest tumor suppression and increased ...
An FDA-approved nuclear export inhibitor killed lab-grown pediatric glioma cells carrying BRAFV600E and, combined with a MEK inhibitor, suppressed regrowth ...
A multi-omics study finds that liver fibrosis involves coordinated cell-type-specific metabolic remodeling, and that the phospholipid POPE reduces hepatic stellate ...
A case report describes over one year of complete remission in BRAF V600E-mutant histiocytic sarcoma using dabrafenib and trametinib maintenance ...
A new review details how the pan-RAS inhibitor daraxonrasib doubled overall survival in a phase III pancreatic cancer trial and ...
A preclinical study reports that the MEK inhibitor cobimetinib suppressed MAPK signaling, tumor cell invasion and immune-evasive features in anaplastic ...
A rat study finds that low-dose tacrolimus lowered right ventricular pressure and reduced pulmonary vascular remodeling through endothelial protection and ...
An exploratory BRIGHT-2 trial analysis associated longitudinal ctDNA patterns with prognosis, molecular response and candidate resistance alterations in advanced breast ...
In preclinical lung squamous cell carcinoma models, GATA6 directly represses BMP2, while elevated BMP2 activates ERK1/2 signaling and promotes tumor-cell ...
A rare pancreatic amphicrine-like carcinoma with acinar differentiation harboring a KANK4::RAF1 gene fusion highlights the diagnostic complexity of dual-differentiation tumors ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine